Melanin as a potential cryptococcal defence against microbicidal proteins

Medical Mycology

Volumn 37, Issue 3, 1999, Pages 175-181

  Doering, Tamara L ^a   Nosanchuk, J D ^b   Roberts, W K ^a   Casadevall, A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cryptococcus neoformans; Defensin; Magainin; Melanin; Protegrin

Indexed keywords

ANTIFUNGAL AGENT; DEFENSIN; MAGAININ DERIVATIVE; MELANIN; PEPTIDE; PROTEGRIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGICIDAL ACTIVITY; FUNGUS CULTURE; FUNGUS IMMUNITY; PH; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; DEFENSINS; FUNGAL PROTEINS; MELANINS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEINS; SOLUTIONS;

FILOBASIDIELLA NEOFORMANS; FUNGI; MAMMALIA;

EID: 0032796921     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1999.00218.x     Document Type: Article

References (31)

1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-548.
2. Wickes BL, Mayorga ME, Edman U, Edman JC. Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type. Proc Natl Acad Sci USA 1996; 95: 7327-7331.
3. Powderly WG. Recent advances in the management of cryptococcal meningitis in patients with AIDS. Clin Infect Dis (Suppl 2) 1996; 22: S119-S123.
4. Kozel TR. Virulence factors of Cryptococcus neoformans. Trends Microbiol 1995; 3: 295-299.
5. Buchanan KL, Murphy JW. What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 1998; 4: 71-83.
6. Hill HZ. The function of melanin or six blind people examine an elephant. BioEssays 1992; 14: 49-56.
7. Polacheck I, Kwon-Chung KJ. Melanogenesis in Cryptococcus neoformans. J Gen Microbiol 1988; 134: 1034-1041.
8. Kwon-Chung KJ, Polacheck I, Popkin TJ. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 1982; 150: 1414-1421.
9. Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence; mechanism of action. Infect Immun 1995; 63: 3131-3136.
10. Wang Y, Aisen P, Casadevall A. Melanin, melanin 'ghosts', and melanin composition in Cryptococcus neoformans. Infect Immun 1996; 64: 2420-2424.
11. Williamson PR. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J Bacteriol 1994; 176: 656-664.
12. Salas SD, Bennett JE, Kwon-Chung KJ, Perfect JR, Williamson PR. Effect of the laccase gene, CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med 1996; 184: 377-386.
13. Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol 1999; 19: 745-750.
14. Jacobson ES, Tinnell SB. Antioxidant function of fungal melanin. J Bacteriol 1993; 175: 7102-7104.
15. Wang Y, Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen-and oxygen-derived oxidants. Infect Immun 1994; 64: 3004-3007.
16. Rosas AL, Casadevall A. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. FEMS Microbiol Lett 1997; 153: 265-272.
17. Wang Y, Casadevall A. Decreased susceptibility of melanized Cryptococcus neoformans to UV light. Appl Environ Microbiol 1994; 60: 3864-3866.
18. Wang Y, Casadevall A. Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicrob Agents Chemother 1994; 38: 2646-2650.
19. Nosanchuk JD, Casadevall A. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun 1997; 65: 1836-1841.
20. Nyhus KJ, Wilborn AT, Jacobson ES. Ferric iron reduction by Cryptococcus neoformans. Inject Immun 1997; 65: 434-438.
21. Huffnagle GB, Chen G-H, Curtis JL, McDonald RA, Stricter RM, Toews GB. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol 1995; 155: 3507-3516.
22. Chen L-C, Pirofski L, Casadevall A. Extracellular proteins of Cryptococcus neoformans and host antibody response. Infect Immun 1997; 65: 2599-2605.
23. White LP. Melanin: a naturally occurring cation exchange material. Nature 1958; 182: 1427-1428.
24. Kwon-Chung KJ, Hill WB, Bennett JE. New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol 1981; 13: 383-387.
25. Alcouloumre MS, Ghannoum MA, Ibrahim AS, Selsted ME, Edwards JE. Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother 1993; 37: 2628-2632.
26. Lehrer RI, Ganz T. Endogenous vertebrate antibiotics: defensins, protegrins, and other cysteine-rick antimicrobial peptides. Ann N Y Acad Sci 1996; 797: 228-239.
27. Jacob L, Zasloff M. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found Symp (Netherlands) 1994; 186: 197-223.
28. Werner-Washburn ME, Braun E, Johsnton GC, Singer RA. Stationary phase in the yeast Saccharomyces cerevisiase. Microbiol Rev 1993; 57: 383-401.
29. Flesch IEA, Schwamberger G, Kaufman SHE. Fungicidal activity of IFN-gamma activated macrophages. J Immunol 1989; 142: 3219-3224.
30. Hiemstra PS, Eisenhauer PB, Harwig LS, van den Barselaar MT, van Furth R, Lehrer RI. Antimicrobial proteins of murine macrophages. Infect Immun 1993; 61: 3038-3046.
31. Lehrer RI, Lichenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993; 11: 105-128.